Optimal antithrombotic therapy for mechanical prosthetic heart valves.
Chesebro
J H
JH
Fuster
V
V
D000368:Aged; D005343:Fibrinolytic Agents / Q000592:standards / Q000627:therapeutic use*; D006350:Heart Valve Prosthesis / Q000009:adverse effects*; D006801:Humans; D008875:Middle Aged; D013923:Thromboembolism / Q000188:drug therapy / Q000209:etiology* / Q000517:prevention & control
D005343:Fibrinolytic Agents